4//SEC Filing
OSS CAPITAL MANAGEMENT 4
Accession 0000902664-09-001108
CIK 0000815838other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:32 PM ET
Size
13.4 KB
Accession
0000902664-09-001108
Insider Transaction Report
Form 4
OSS CAPITAL MANAGEMENT
10% Owner
Transactions
- Sale
Common Stock ($.0001 par value)
2009-03-10$9.00/sh−11,324$101,916→ 2,486,444 total(indirect: See Footnote)
Schafer Brother LLC
10% Owner
Transactions
- Sale
Common Stock ($.0001 par value)
2009-03-10$9.00/sh−11,324$101,916→ 2,486,444 total(indirect: See Footnote)
SCHAFER OSCAR
10% Owner
Transactions
- Sale
Common Stock ($.0001 par value)
2009-03-10$9.00/sh−11,324$101,916→ 2,486,444 total(indirect: See Footnote)
Goffe Andrew J.
10% Owner
Transactions
- Sale
Common Stock ($.0001 par value)
2009-03-10$9.00/sh−11,324$101,916→ 2,486,444 total(indirect: See Footnote)
Footnotes (5)
- [F1]This Form 4 is being filed to report that O.S.S. Capital Management LP, a Delaware limited partnership (the "Investment Manager"), Schafer Brothers LLC, a Delaware limited liability company ("SB LLC"), Mr. Oscar S. Schafer ("Mr. Schafer") and Mr. Andrew Goffe ("Mr. Goffe", collectively with the Investment Manager, SB LLC and Mr. Shafer, the "Reporting Persons") have sold 11,324 shares of Noven Pharmaceuticals Inc. common stock.
- [F2]The Reporting Persons have investment discretion with respect to securities held by a Cayman Islands exempted company and two Delaware limited partnerships as more fully described in the Form 3 filed on July 16, 2007 (Accession Number: 0000902664-07-002296), the Form 4 filed on August 8, 2007 (Accession Number: 0000902664-07-002474), the Form 4 filed on August 14, 2007 (Accession Number 0000902664-07-002630), the Form 4 filed on September 12, 2007 (Accession Number 0000902664-07-002795), the Form 4 filed on September 14, 2007 (Accession Number 0000902664-07-002815), the Form 4 filed on September 17, 2007 (Accession Number 0000902664-07-002830), the Form 4 filed on October 2, 2007 (Accession Number 0000902664-07-002925), the Form 4 filed on March 17, 2008 (Accession Number: 0000902664-08-001576), the Form 4 filed on March 31, 2008 (Accession Number 0000902664-08-001729), the Form 4 filed on October 31, 2008 (Accession Number: 0000902664-08-003101),
- [F3](Footnote 2 cont'd) the Form 4 filed on December 29, 2008 (Accession Number: 0000902664-08-003465), the Form 4 filed on December 31, 2008 (Accession Number: 0000902664-08-003494), the Form 4 filed on January 5, 2009 (Accession Number: 0000902664-09-000011), the Form 4 filed on January 7, 2009 (Accession Number: 0000902664-09-000023), the Form 4 filed on January 9, 2009 (Accession Number: 0000902664-09-000039), the Form 4 filed on January 13, 2009 (Accession Number: 0000902664-09-000050), the Form 4 filed on January 21, 2009 (Accession Number: 0000902664-09-000134), the Form 4 filed on January 29, 2009 (Accession Number: 0000902664-09-000233), the Form 4 filed on February 2, 2009 (Accession Number: 0000902664-09-000284), the Form 4 filed on February 17, 2009 (Accession Number: 0000902664-09-000924), the Form 4 filed on February 19, 2009 (Accession Number: 0000902664-09-001041) the Form 4 filed on February 23, 2009 (Accession Number: 0000902664-09-001048),
- [F4](Footnote 3 cont'd) the Form 4 filed on March 4, 2009 (Accession Number: 0000902664-09-001083) and the Form 4 filed on March 6, 2009 (Accession Number: 0000902664-09-001099).
- [F5]Each of the Reporting Persons may be deemed to beneficially own 2,486,444 shares of common stock, which represent, together, approximately 9.9% of the outstanding shares of common stock. Each of the Reporting Persons disclaims beneficial ownership of the securities included in this report and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of such person's pecuniary interest therein.
Issuer
NOVEN PHARMACEUTICALS INC
CIK 0000815838
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001218321
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 8:32 PM ET
- Size
- 13.4 KB